Alzheimer'S Precision Medicine

Alzheimer's precision medicine aims to tailor treatments to the specific genetic, molecular, and clinical characteristics of individuals affected by Alzheimer’s disease and dementia. By leveraging advancements in genetics, biomarkers, and neuroimaging, researchers seek to identify personalized therapies that can effectively slow disease progression or alleviate symptoms based on each patient’s unique profile.

This approach contrasts with traditional one-size-fits-all treatments, recognizing the complex and varied nature of Alzheimer's disease among different individuals. Precision medicine in Alzheimer's holds promise in predicting disease risk, selecting appropriate interventions, and optimizing therapeutic outcomes, ultimately striving towards more targeted and effective care strategies. As research continues to uncover deeper insights into the underlying mechanisms of Alzheimer's, the development and application of precision medicine approaches offer hope for more personalized and impactful treatments in the future.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France
Tags

Submit your abstract Today

Whatsapp